Keith McCrae, MD, on Managing Heparin-Induced Thrombocytopenia

2014 ASH Annual Meeting
Tweet this page

Keith McCrae, MD, of the Cleveland Clinic, offers his thoughts on abstract 4848, “Implementation of a Heparin-Induced Thrombocytopenia Management Program Reduces the Cost of Diagnostic Testing and Pharmacologic Treatment in an Academic Medical Center,” presented by Caroline Dupre Vaughn, RN.

Advertisement

Advertisement



Advertisement